Daluyon, Arlyn O.
HRN: 23-94-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2023
CEFTRIAXONE 1G (VIAL)
11/04/2023
11/11/2023
IV
2g
Q24
Bilateral Effusion, CAP-MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes